glp 1 kidney disease GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal GLP-1 in kidney disease? #obesitydoctor

Mitophagy stimulation as a novel strategy for the treatment of mitochondrial diseases

KPV does something different

HCG injections are given in medical clinics or weight loss centers

This specific side-effect makes GHRP-6 highly prioritized in research models involving cachexia, wasting syndromes, or intentional hyper-caloric ingestion protocols

Abdelrahman SA, Raafat N, Abdelaal GMM, Aal SMA (2023) Electric field-directed migration of mesenchymal stem cells enhances their therapeutic potential on cisplatin-induced acute nephrotoxicity in rats

Following this, these medications were studied extensively in clinical trials before being approved by the MHRA (Medicines and Healthcare products Regulatory Agency)